A clinical trial at the University of Arizona Health Sciences designed to study the safety and effectiveness of a personalised cancer vaccine in combination with the immunotherapy drug Pembrolizumab will expand its cohort after promising preliminary data was presented at the annual meeting of the Society for the Immunotherapy of Cancer. Julie E. Bauman, MD, … Continue reading Small personalised cancer vaccine clinical trial to expand following promising early results